Movatterモバイル変換


[0]ホーム

URL:


SG10201407036YA - Markers of Endothelial Progenitor Cells and Uses Thereof - Google Patents

Markers of Endothelial Progenitor Cells and Uses Thereof

Info

Publication number
SG10201407036YA
SG10201407036YASG10201407036YASG10201407036YASG10201407036YASG 10201407036Y ASG10201407036Y ASG 10201407036YASG 10201407036Y ASG10201407036Y ASG 10201407036YASG 10201407036Y ASG10201407036Y ASG 10201407036YASG 10201407036Y ASG10201407036Y ASG 10201407036YA
Authority
SG
Singapore
Prior art keywords
markers
progenitor cells
endothelial progenitor
epc
cells
Prior art date
Application number
SG10201407036YA
Inventor
Sharon Bonder Claudine
Fransciso Lopez Angel
Hoy Talbo Gert
Original Assignee
Transbio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transbio LtdfiledCriticalTransbio Ltd
Publication of SG10201407036YApublicationCriticalpatent/SG10201407036YA/en

Links

Classifications

Landscapes

Abstract

MARKERS OF ENDOTHELIAL PROGENITOR CELLS AND USES THEREOF The present invention provides markers of endothelial progenitor cells (EPCs) and use of those markers and reagents that bind thereto to detect EPC cells or diagnose, prognose, treat or prevent EPC-associated conditions. (No Figure Suitable for Reproduction)
SG10201407036YA2010-11-052011-11-07Markers of Endothelial Progenitor Cells and Uses ThereofSG10201407036YA (en)

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
US41067410P2010-11-052010-11-05

Publications (1)

Publication NumberPublication Date
SG10201407036YAtrue SG10201407036YA (en)2014-12-30

Family

ID=46023871

Family Applications (2)

Application NumberTitlePriority DateFiling Date
SG2013029855ASG189475A1 (en)2010-11-052011-11-07Markers of endothelial progenitor cells and uses thereof
SG10201407036YASG10201407036YA (en)2010-11-052011-11-07Markers of Endothelial Progenitor Cells and Uses Thereof

Family Applications Before (1)

Application NumberTitlePriority DateFiling Date
SG2013029855ASG189475A1 (en)2010-11-052011-11-07Markers of endothelial progenitor cells and uses thereof

Country Status (8)

CountryLink
US (2)US20130224116A1 (en)
EP (1)EP2635674A4 (en)
JP (1)JP6296536B2 (en)
AU (1)AU2011325871B2 (en)
CA (1)CA2816763A1 (en)
NZ (1)NZ609567A (en)
SG (2)SG189475A1 (en)
WO (1)WO2012058726A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
JP6461787B2 (en)*2013-04-122019-01-30国立大学法人京都大学 Method for inducing alveolar epithelial progenitor cells
JP2017514523A (en)*2014-05-092017-06-08メドベット サイエンス ピーティーワイエルティーディーMedvet Science Pty Ltd Cell culture method
CN104502604B (en)*2014-12-032016-04-06上海交通大学医学院附属上海儿童医学中心 NCX1 and NCKX4 as markers for diagnosing closure or patency of the ductus arteriosus
JP6738572B2 (en)2015-03-062020-08-12国立大学法人京都大学 Method for inducing differentiation of alveolar epithelial cells
WO2016185457A1 (en)2015-05-192016-11-24Yeda Research And Development Co. Ltd.Methods of promoting lymphangiogenesis
MA43282A (en)*2015-11-192018-09-26Abbvie Stemcentrx Llc NEW ANTI-EMR2 ANTIBODIES AND RELATED METHODS OF USE
US10767164B2 (en)2017-03-302020-09-08The Research Foundation For The State University Of New YorkMicroenvironments for self-assembly of islet organoids from stem cells differentiation
EP4255484A4 (en)*2020-12-022025-02-26Univ Jefferson DESMOGLEIN-2-TARGETED CHIMERIC ANTIGEN RECEPTOR CONSTRUCTS AND METHODS OF USE
PE20242205A1 (en)*2021-04-262024-11-19Millennium Pharm Inc ANTI-ADGRE2 ANTIBODIES AND THEIR USES

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US645563A (en)1899-07-061900-03-20Mark L HeathPocket-knife.
US4196265A (en)1977-06-151980-04-01The Wistar InstituteMethod of producing antibodies
US4560655A (en)1982-12-161985-12-24Immunex CorporationSerum-free cell culture medium and process for making same
US4657866A (en)1982-12-211987-04-14Sudhir KumarSerum-free, synthetic, completely chemically defined tissue culture media
GB8308235D0 (en)1983-03-251983-05-05Celltech LtdPolypeptides
US4816567A (en)1983-04-081989-03-28Genentech, Inc.Recombinant immunoglobin preparations
US4767704A (en)1983-10-071988-08-30Columbia University In The City Of New YorkProtein-free culture medium
US5807715A (en)1984-08-271998-09-15The Board Of Trustees Of The Leland Stanford Junior UniversityMethods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
US4879231A (en)1984-10-301989-11-07Phillips Petroleum CompanyTransformation of yeasts of the genus pichia
US4709017A (en)1985-06-071987-11-24President And Fellows Of Harvard CollegeModified toxic vaccines
GB8516415D0 (en)1985-06-281985-07-31Celltech LtdCulture of animal cells
US4676980A (en)1985-09-231987-06-30The United States Of America As Represented By The Secretary Of The Department Of Health And Human ServicesTarget specific cross-linked heteroantibodies
US6548640B1 (en)1986-03-272003-04-15Btg International LimitedAltered antibodies
US4927762A (en)1986-04-011990-05-22Cell Enterprises, Inc.Cell culture medium with antioxidant
IL85035A0 (en)1987-01-081988-06-30Int Genetic EngPolynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
AU600575B2 (en)1987-03-181990-08-16Sb2, Inc.Altered antibodies
US6710169B2 (en)1987-10-022004-03-23Genentech, Inc.Adheson variants
US5223409A (en)1988-09-021993-06-29Protein Engineering Corp.Directed evolution of novel binding proteins
WO1990003430A1 (en)1988-09-231990-04-05Cetus CorporationCell culture medium for enhanced cell growth, culture longevity and product expression
SE8804074D0 (en)1988-11-101988-11-10Pharmacia Ab SENSOR UNIT AND ITS USE IN BIOSENSOR SYSTEM
US5530101A (en)1988-12-281996-06-25Protein Design Labs, Inc.Humanized immunoglobulins
CA2062795A1 (en)1989-06-291990-12-30Michael W. FangerBispecific reagents for aids therapy
US5859205A (en)1989-12-211999-01-12Celltech LimitedHumanised antibodies
AU8295491A (en)1990-06-291992-01-23Biosource Technologies IncorporatedMelanin production by transformed microorganisms
GB9015198D0 (en)1990-07-101990-08-29Brien Caroline J OBinding substance
US5194594A (en)1990-09-071993-03-16Techniclone, Inc.Modified antibodies
US5122469A (en)1990-10-031992-06-16Genentech, Inc.Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
US5709859A (en)1991-01-241998-01-20Bristol-Myers Squibb CompanyMixed specificity fusion proteins
WO1994004679A1 (en)1991-06-141994-03-03Genentech, Inc.Method for making humanized antibodies
WO1992022653A1 (en)1991-06-141992-12-23Genentech, Inc.Method for making humanized antibodies
US5565332A (en)1991-09-231996-10-15Medical Research CouncilProduction of chimeric antibodies - a combinatorial approach
US5733731A (en)1991-10-161998-03-31Affymax Technologies N.V.Peptide library and screening method
WO1993008829A1 (en)1991-11-041993-05-13The Regents Of The University Of CaliforniaCompositions that mediate killing of hiv-infected cells
ATE408012T1 (en)1991-12-022008-09-15Medical Res Council PRODUCTION OF AUTOANTIBODIES ON PHAGE SURFACES BASED ON ANTIBODIES SEGMENT LIBRARIES
ZA932522B (en)1992-04-101993-12-20Res Dev FoundationImmunotoxins directed against c-erbB-2(HER/neu) related surface antigens
EP0643559B1 (en)1992-05-061999-04-14The President And Fellows Of Harvard CollegeDiphtheria toxin receptor-binding region
JP3428646B2 (en)1992-06-182003-07-22プレジデント アンド フェローズ オブ ハーバードカレッジ Diphtheria toxin vaccine
JPH08500017A (en)1992-08-171996-01-09ジェネンテク,インコーポレイテッド Bispecific immune adhesin
US5591646A (en)1992-09-021997-01-07Arris PharmaceuticalMethod and apparatus for peptide synthesis and screening
US5917017A (en)1994-06-081999-06-29President And Fellows Of Harvard CollegeDiphtheria toxin vaccines bearing a mutated R domain
US5485277A (en)1994-07-261996-01-16Physical Optics CorporationSurface plasmon resonance sensor and methods for the utilization thereof
US5463564A (en)1994-09-161995-10-313-Dimensional Pharmaceuticals, Inc.System and method of automatically generating chemical compounds with desired properties
AU4289496A (en)1994-12-021996-06-19Chiron CorporationMethod of promoting an immune response with a bispecific antibody
US5731168A (en)1995-03-011998-03-24Genentech, Inc.Method for making heteromultimeric polypeptides
US5567301A (en)1995-03-011996-10-22Illinois Institute Of TechnologyAntibody covalently bound film immunobiosensor
US5739277A (en)1995-04-141998-04-14Genentech Inc.Altered polypeptides with increased half-life
US5834318A (en)1995-05-101998-11-10Bayer CorporationScreening of combinatorial peptide libraries for selection of peptide ligand useful in affinity purification of target proteins
EP1033411B1 (en)1996-06-042006-02-22University of Utah Research FoundationFluorescent donor-acceptor pair
US5922845A (en)1996-07-111999-07-13Medarex, Inc.Therapeutic multispecific compounds comprised of anti-Fcα receptor antibodies
US5980887A (en)*1996-11-081999-11-09St. Elizabeth's Medical Center Of BostonMethods for enhancing angiogenesis with endothelial progenitor cells
CA2297070A1 (en)1997-08-011999-02-11Morphosys AgNovel method and phage for the identification of nucleic acid sequences encoding members of a multimeric (poly)peptide complex
US6506559B1 (en)1997-12-232003-01-14Carnegie Institute Of WashingtonGenetic inhibition by double-stranded RNA
CN101818145A (en)1998-03-202010-09-01联邦科学和工业研究组织Control of gene expression
NZ507093A (en)1998-04-082003-08-29Commw Scient Ind Res OrgMethods and means for reducing the phenotypic expression of a nucleic acid of interest in a plant
AU3657899A (en)1998-04-201999-11-08James E. BaileyGlycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
US6306610B1 (en)1998-09-182001-10-23Massachusetts Institute Of TechnologyBiological applications of quantum dots
KR100379411B1 (en)1999-06-282003-04-10엘지전자 주식회사biochip and method for patterning and measuring biomaterial of the same
US6326193B1 (en)1999-11-052001-12-04Cambria Biosciences, LlcInsect control agent
US6523392B2 (en)2000-01-252003-02-25Arizona Board Of RegentsMicrocantilever sensor
JP4425420B2 (en)2000-04-032010-03-03独立行政法人理化学研究所 Microarray production equipment
US20020102617A1 (en)2000-08-032002-08-01Macbeath GavinProtein microarrays
US6596541B2 (en)2000-10-312003-07-22Regeneron Pharmaceuticals, Inc.Methods of modifying eukaryotic cells
US8178098B2 (en)2001-04-032012-05-15National Jewish HealthMethod to inhibit airway hyperresponsiveness using aerosolized T cell receptor antibodies
US20020192654A1 (en)2001-06-152002-12-19Tao-Kuang ChangBio-chip substrate for the embedding of DNA or protein and its fabrication method
ES2669510T3 (en)2004-09-232018-05-28Genentech, Inc. Antibodies and conjugates engineered with cysteine
AU2006256650A1 (en)*2005-06-062006-12-14Glykos Finland OyMethod of profiling a cell population
EP1746161A1 (en)2005-07-202007-01-24CytherisGlycosylated IL-7, preparation and uses
US11392902B2 (en)2017-06-062022-07-19United Parcel Service Of America, Inc.Systems, methods, apparatuses and computer program products for providing notification of items for pickup and delivery

Also Published As

Publication numberPublication date
EP2635674A1 (en)2013-09-11
SG189475A1 (en)2013-05-31
AU2011325871B2 (en)2016-02-04
NZ609567A (en)2015-05-29
US20160053318A1 (en)2016-02-25
JP2013544085A (en)2013-12-12
US20130224116A1 (en)2013-08-29
WO2012058726A1 (en)2012-05-10
AU2011325871A1 (en)2013-04-11
CA2816763A1 (en)2012-05-10
JP6296536B2 (en)2018-03-20
EP2635674A4 (en)2014-11-05

Similar Documents

PublicationPublication DateTitle
SG10201407036YA (en)Markers of Endothelial Progenitor Cells and Uses Thereof
MX2011011925A (en)Tri- or tetraspecific antibodies.
MX345909B (en)Anti-fgfr3 antibodies and methods using same.
UA114901C2 (en)Acc inhibitors and uses thereof
EP4450644A3 (en)Increasing dynamic range for identifying multiple epitopes in cells
MX2019008212A (en)Fibrous structures comprising particles and methods for making same.
TN2011000673A1 (en)Bace inhibitors
GB2522366A (en)Mapping cytosine modifications
MX2013001473A (en)Antibodies against il-18r1 and uses thereof.
MY159553A (en)Detection and treatment of pancreatic, ovarian and other cancers
MX2015003874A (en)Modulation of ire1.
EA201171367A1 (en) VINYLINDASOLYL COMPOUNDS
PH12013500065A1 (en)Deuterated n-ethyl-n-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereof
MX354356B (en)METHODS and SYSTEMS FOR DETECTION OF MICROORGANISMS.
NZ704718A (en)Epcam aptamer for detection of cancer stem cells
MX336323B (en)Anti-polyubiquitin antibodies and methods of use.
MX337203B (en)Novel jnk inhibitor molecules.
MY161868A (en)Anti-bv8 antibodies and uses thereof
WO2011047058A3 (en)Assay for the prediction of therapeutic effectiveness of mesenchymal stromal cells, and methods of using same
WO2012058220A3 (en)Anti-sod1 antibodies and uses thereof
PH12013500944A1 (en)Methods and compositions for drying coal
MY154715A (en)Anti-nr10 antibody and use thereof
EP3792634A3 (en)Method of assaying 5-fu
WO2011140334A3 (en)Compounds, methods of making or identifying compounds, and uses thereof
GB2480792A (en)Rapid oligo probes

[8]ページ先頭

©2009-2025 Movatter.jp